Simulations Plus Income Taxes 2010-2025 | SLP
Simulations Plus income taxes from 2010 to 2025. Income taxes can be defined as the total amount of income tax expense for the given period.
Simulations Plus Annual Income Taxes
(Millions of US $) |
| 2024 |
$2 |
| 2023 |
$2 |
| 2022 |
$3 |
| 2021 |
$1 |
| 2020 |
$2 |
| 2019 |
$2 |
| 2018 |
$1 |
| 2017 |
$2 |
| 2016 |
$2 |
| 2015 |
$2 |
| 2014 |
$1 |
| 2013 |
$1 |
| 2012 |
$1 |
| 2011 |
$1 |
| 2010 |
$1 |
| 2009 |
$1 |
Simulations Plus Quarterly Income Taxes
(Millions of US $) |
| 2025-02-28 |
$0 |
| 2024-11-30 |
$0 |
| 2024-08-31 |
$0 |
| 2024-05-31 |
$1 |
| 2024-02-29 |
$1 |
| 2023-11-30 |
$0 |
| 2023-08-31 |
$0 |
| 2023-05-31 |
$1 |
| 2023-02-28 |
$1 |
| 2022-11-30 |
$0 |
| 2022-08-31 |
$0 |
| 2022-05-31 |
$1 |
| 2022-02-28 |
$1 |
| 2021-11-30 |
$1 |
| 2021-08-31 |
$0 |
| 2021-05-31 |
$1 |
| 2021-02-28 |
$0 |
| 2020-11-30 |
$1 |
| 2020-08-31 |
$0 |
| 2020-05-31 |
$1 |
| 2020-02-29 |
$1 |
| 2019-11-30 |
$1 |
| 2019-08-31 |
$0 |
| 2019-05-31 |
$1 |
| 2019-02-28 |
$1 |
| 2018-11-30 |
$0 |
| 2018-08-31 |
$1 |
| 2018-05-31 |
$1 |
| 2018-02-28 |
$-1 |
| 2017-11-30 |
$1 |
| 2017-08-31 |
$0 |
| 2017-05-31 |
$1 |
| 2017-02-28 |
$1 |
| 2016-11-30 |
$1 |
| 2016-08-31 |
$0 |
| 2016-05-31 |
$1 |
| 2016-02-29 |
$1 |
| 2015-11-30 |
$1 |
| 2015-08-31 |
$0 |
| 2015-05-31 |
$1 |
| 2015-02-28 |
$0 |
| 2014-11-30 |
$0 |
| 2014-08-31 |
$0 |
| 2014-05-31 |
$1 |
| 2014-02-28 |
$0 |
| 2013-11-30 |
$0 |
| 2013-08-31 |
$0 |
| 2013-05-31 |
$1 |
| 2013-02-28 |
$1 |
| 2012-11-30 |
$0 |
| 2012-08-31 |
$0 |
| 2012-05-31 |
$0 |
| 2012-02-29 |
$0 |
| 2011-11-30 |
$0 |
| 2011-08-31 |
|
| 2011-05-31 |
$0 |
| 2011-02-28 |
$0 |
| 2010-11-30 |
$0 |
| 2010-08-31 |
$0 |
| 2010-05-31 |
$0 |
| 2010-02-28 |
$0 |
| 2009-11-30 |
$0 |
| 2009-08-31 |
$0 |
| 2009-05-31 |
$0 |
| 2009-02-28 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.339B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
